Carbohydrate chemistry occupies a unique and underserved niche in the CRO landscape. Saccharides are far more than simple energy sources; they are critical mediators of biological recognition, signaling, and structural integrity. In drug development, oligosaccharides and their derivatives play pivotal roles in vaccine design, antibody optimization, and the creation of glycoconjugates for targeted therapies. Their precise synthesis, however, presents unique challenges: stereochemical complexity, regiospecific modifications, and the need for scalable, reproducible processes that most generalist CROs are not equipped to handle.

At Oxeltis, we have mastered these challenges over 15+ years of challenging synthesis. Our expertise spans the synthesis of ribose derivatives, hexoses, and custom oligosaccharides, including rare or modified sugars tailored to your project's specifications. Whether you require gram-scale quantities for preclinical studies or optimized routes for complex glycans, our team delivers compounds with the purity, consistency, and structural fidelity demanded by cutting-edge glycoscience research.

Our approach is rooted in collaboration: we work closely with your team to define specifications, troubleshoot synthetic challenges, and iterate rapidly to meet your goals. We adapt to your timeline and scale, whether you are at the hit-to-lead stage or advancing toward IND-enabling studies. Your projects are treated with full discretion, and we offer flexible agreements to protect your intellectual property.